Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;7(5):100.
doi: 10.21037/atm.2019.01.69.

Clinicopathological characteristics and treatment strategies for young lung cancer patients

Affiliations

Clinicopathological characteristics and treatment strategies for young lung cancer patients

Remi Yoneyama et al. Ann Transl Med. 2019 Mar.

Abstract

Background: The reported age-specific survival rates of lung cancer patients have been largely inconsistent. Management strategies for younger patients and treatment outcomes are not well characterized.

Methods: Out of the 4,697 lung cancer patients with treatment history at Tokyo Medical University Hospital between January 2000 and December 2014, 266 patients were <49 years of age. Patient characteristics were investigated, and the association of overall survival (OS) with age, sex, stage, and histological type were investigated.

Results: The 1-, 3-, and 5-year survival rates in the ≤49 years age group were 82.9%, 64.6%, and 57.0%. Among surgical cases, the survival rate of patients in the ≤49 years age group was significantly better than that in the 50-69 and ≥70 years age groups (P=0.29 and P<0.0001, respectively). In comparison with the OS rate with clinical stages, I, II, and III (but not with clinical stage IV) in the older than 50 years age group, the rates in the ≤49 years age group were better. The 1-, 3-, and 5-year OS rates of females were higher than those of their males. The 1-, 3-, and 5-year OS rates for lung adenocarcinoma patients were higher than that of lung non-adenocarcinoma patients.

Conclusions: Despite the higher proportion of advanced disease, the postoperative survival rate of the younger was higher than that of the older. Aggressive multimodality treatments, including surgery, are more feasible and effective for younger patients as compared with that in older patients.

Keywords: Young lung cancer patients; adenocarcinoma; lung cancer; survival.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Kaplan-Meier curves for 1-, 3-, and 5-year overall survival of lung cancer patients according to (A) all patients (P=0.0001), (B) surgical cases (P=0.0001), and (C) non-surgical cases in the age group of ≤49, 50–69, and ≥70.
Figure 2
Figure 2
Kaplan-Meier curves for 1-, 3-, and 5-year overall survival of lung cancer patients according to (A) stage 1 (P=0.0001), (B) stage 2 (P=0.0001), (C) stage 3 (P=0.0001), and (D) stage 4 in the age group of ≤49, 50–69, and ≥70.
Figure 3
Figure 3
Kaplan-Meier curves for 1-, 3-, and 5-year overall survival of lung cancer patients according to (A) sex and age (P=0.0001) and (B) histology and age (P=0.0001) in the age group of ≤49, 50–69, and ≥70.

References

    1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108. 10.3322/caac.21262 - DOI - PubMed
    1. Key Statistics for Lung Cancer. Available online: https://www.cancer.org/cancer/non-small-cell-lung-cancer/about/key-stati..., Accessed 05.29, 2017.
    1. Sawabata N, Miyaoka E, Asamura H, et al. Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol 2011;6:1229-35. 10.1097/JTO.0b013e318219aae2 - DOI - PubMed
    1. Radzikowska E, Roszkowski K, Glaz P. Lung cancer in patients under 50 years old. Lung Cancer 2001;33:203-11. 10.1016/S0169-5002(01)00199-4 - DOI - PubMed
    1. Tian DL, Liu HX, Zhang L, et al. Surgery for young patients with lung cancer. Lung Cancer 2003;42:215-20. 10.1016/S0169-5002(03)00286-1 - DOI - PubMed